FDA finds deficiencies in Mylan's generic Advair

(Reuters) - U.S. drugmaker Mylan NV said on Wednesday that U.S. health regulators could not approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug, Advair, and cited "minor deficiencies" with the copycat version.

Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

ATM stolen from business in Bracebridge

Provincial Police are investigating a break and enter after an ATM was stolen from a business in Bracebridge early Saturday morning.

0 0

New court documents shed light on Sandy Hook shooter

New court documents obtained by The Hartford Courtant shed light on the state of mind of the Sandy Hook shooter Adam Lanza. CBSN spoke with the newpaper's Dave Altimari about what they found.

0 0

Reserve Bank of India governor Urjit Patel resigns

The Reserve Bank of India has lost its second chief in less than three years, raising questions about the central bank's independence and the management of the economy going into an election year.

0 0

Google says Google+ bug affected 52.5 million users

Google will shut down its Google+ social network much sooner than planned after discovering a second bug that revealed millions of customers' private information to software developers.

0 0

Whoops, looks like something went wrong.